Efficacy of combination therapy with zoledronic acid and cetuximab for unresectable rectal cancer with bone metastases: A case report

The combination of cetuximab (CTX) and chemotherapy, such as FOLFOX or FOLFIRI, is currently the standard treatment for metastatic colorectal cancer (mCRC). Zoledronic acid (ZOL) is used in patients with bone metastasis. We herein report our experience with the case of a 58-year-old male patient wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Tokumaru, Yoshihisa, Matsuhashi, Nobuhisa, Takahashi, Takao, Tanahashi, Toshiyuki, Matsui, Satoshi, Imai, Hisashi, Tanaka, Yoshihiro, Yamaguchi, Kazuya, Yoshida, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482389/
https://www.ncbi.nlm.nih.gov/pubmed/31031973
http://dx.doi.org/10.3892/mco.2019.1836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482389/
https://www.ncbi.nlm.nih.gov/pubmed/31031973
http://dx.doi.org/10.3892/mco.2019.1836

Ejemplares similares